Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.85 is in line with its 5-year average of 7.61, around the middle of its 5-year range (2.67–12.95).
As of the fiscal period ended Tuesday, June 30, 2026. 1.69% below its 12-month average of 7.98.
Reported quarterly current ratio; no daily interpolation.
CURRENT RATIO
7.85
CURRENT RATIO AVG TTM
7.98
CURRENT RATIO AVG 3Y
8.78
CURRENT RATIO AVG 5Y
7.61
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.69%
CURRENT VS 3Y AVG
-10.63%
CURRENT VS 5Y AVG
+3.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.54
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+409.61%
vs the sector median at left
Market Cap
$23.84B
Current Ratio
2.82
TTM Avg
2.91
3Y Avg
3.10
5Y Avg
3.01
Market Cap
$25.90B
Current Ratio
1.59
TTM Avg
1.07
3Y Avg
1.17
5Y Avg
1.32
Market Cap
$26.18B
Current Ratio
1.12
TTM Avg
1.08
3Y Avg
1.10
5Y Avg
1.13
Market Cap
$21.45B
Current Ratio
5.73
TTM Avg
5.92
3Y Avg
6.53
5Y Avg
6.74
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.67B | 7.85 | 7.98 | 8.78 | 7.61 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.84B | 2.82 | 2.91 | 3.10 | 3.01 |
| Incyte Corporation (INCY)vs › | $25.71B | 4.66 | 2.65 | 3.15 | 3.33 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.90B | 1.59 | 1.07 | 1.17 | 1.32 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.18B | 1.12 | 1.08 | 1.10 | 1.13 |
| Labcorp Holdings Inc. (LH)vs › | $26.36B | 1.80 | 1.43 | 1.38 | 1.52 |
| United Therapeutics Corporation (UTHR)vs › | $21.45B | 5.73 | 5.92 | 6.53 | 6.74 |
| STERIS plc (STE)vs › | $21.03B | 1.91 | 2.02 | 2.37 | 2.27 |
| Medline Inc. (MDLN)vs › | $28.80B | 4.33 | 3.84 | 3.94 | 3.94 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.54B | 1.02 | 1.09 | 1.07 | 1.01 |
Current Ratio
7.85
Quick Ratio
7.80
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.85 |
| 2026-03-31 | 8.80 |
| 2025-12-31 | 7.54 |
| 2025-09-30 | 7.12 |
| 2025-06-30 | 8.61 |
| 2025-03-31 | 10.18 |
| 2024-12-31 | 7.45 |
| 2024-09-30 | 7.33 |
| 2024-06-30 | 7.54 |
| 2024-03-31 | 11.38 |
| 2023-12-31 | 9.43 |
| 2023-09-30 | 10.37 |
| 2023-06-30 | 10.56 |
| 2023-03-31 | 12.95 |
| 2022-12-31 | 7.43 |
| 2022-09-30 | 5.37 |
| 2022-06-30 | 5.15 |
| 2022-03-31 | 5.05 |
| 2021-12-31 | 4.33 |
| 2021-09-30 | 2.75 |
| 2021-06-30 | 2.67 |
| 2021-03-31 | 2.70 |
| 2020-12-31 | 2.75 |
| 2020-09-30 | 4.07 |
| 2020-06-30 | 2.98 |
| 2020-03-31 | 3.47 |
| 2019-12-31 | 4.05 |
| 2019-09-30 | 3.91 |
| 2019-06-30 | 3.71 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 3.56 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
